-
Sector Analysis
KRAS Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036
KRAS Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area. Kirsten Rat Sarcoma (KRAS) is a downstream signaling molecule in the EGFR cellular pathway with roles in cell growth and proliferation.KRAS gene tests are carried out to detect gene mutations in patient tissue samples; the outcome of which may guide therapies to treat various cancers including colorectal cancer, certain lung cancers and...
-
Sector Analysis
Next Generation Sequencers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036
Next Generation Sequencers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area. Next-generation sequencers are instruments used to determine the nucleotide sequence of DNA or RNA rapidly and efficiently. Offering an efficient throughput per sequencing, next-generation sequencers are capable of massively parallel processing and are instrumental in uncovering genetic variations, understanding complex diseases, and advancing research in areas such as cancer...
-
Sector Analysis
PD-L1 Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036
PD-L1 Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036 is built to visualize quantitative and qualitative market trends within In-Vitro Diagnostics Devices therapeutic area. Programmed death ligand-1 (PD-L1) is a protein found on tumor cells. High expression of PD-L1 is linked to more aggressive and fast-growing cancers due to the immune system not being as effective as it should be in attacking cancer cells. PD-L1 interacts with PD-L1 (found on immune T-cells) to deactivate the immune...
-
Sector Analysis
BRCA Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036
BRCA Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area. Breast cancer type 1 (BRCA1) and Breast cancer type 1 (BRCA1 gene tests, under the overall umbrella of BRCA Tests, are carried out to detect gene rearrangements within blood samples; the outcome of which may guide therapies and prophylactic actions to treat or prevent certain types of breast and ovarian cancer. Breast...
-
Sector Analysis
BRAF Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036
BRAF Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area. BRAF tests are carried out to detect either the BRAF V600 mutant protein or mutations in the BRAF gene, using biopsied tissue, the outcome of which may guide therapies to treat melanoma cancer. The BRAF gene belongs to a class of genes known as oncogenes. When mutated, oncogenes have the potential to...
-
Sector Analysis
ALK Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036
ALK Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 is built to visualize quantitative and qualitative market trends trends within In Vitro Diagnostics therapeutic area. Anaplastic Lymphoma Receptor Tyrosine Kinase (ALK) gene tests are carried out to detect gene rearrangements within non-small cell lung cancer tumor cells; the outcome of which may guide therapies to treat non-small cell lung cancer (NSCLC). ALK is a member of the receptor tyrosine kinase family and a major factor in...
-
Sector Analysis
Hemostasis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036
Hemostasis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area. Hemostasis screening tests help to identify patients with hemostatic defects. These tests helps to predict bleeding risk in surgeries and to identify specific defects in patients with a history of excessive bruising or bleeding.These tests are also used in monitoring patients who take medications (Oral anticoagulants or Vit-k antagonists) that affect clotting...
-
Sector Analysis
Hematology Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036
Hematology Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area. Hematology is the study of blood in health and disease. It includes problems with the red blood cells, white blood cells, platelets, blood vessels, bone marrow, lymph nodes, spleen, and the proteins involved in bleeding and clotting (hemostasis and thrombosis). Hematology tests include various blood tests that help diagnose and monitor various...
-
Sector Analysis
Point of Care (POC) Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036
Point of Care (POC) Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area. Point of Care (POC) analyzers are small-size, handheld, or bench-top analyzers. Point of Care Testing (POC) is defined as medical diagnostic testing performed outside the clinical laboratory in close proximity to where the patient is receiving care. POC is typically performed by non-laboratory personnel and the results...
-
Sector Analysis
Polymerase Chain Reaction (PCR) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036
Polymerase Chain Reaction (PCR) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area. The Polymerase chain reaction (PCR) is a method used to amplify and analyze short DNA (or RNA) sequences in a sample with small quantities of RNA or DNA, through repeated heating and cooling of nucleic acids, combined with recombinant enzymes, to mimic the natural process used in...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.